Global Consensus on the Management of Limbal Stem Cell Deficiency | ASCRS
Menu
Home Clinical Education Cornea Global Consensus on the Management of Limbal Stem Cell Deficiency
Presentation
Global Consensus on the Management of Limbal Stem Cell Deficiency
July 2021
Meeting: 2021 ASCRS Annual Meeting
Session: SYM-19 Challenges and Controversies in the Management of Anterior Segment Diseases
Presenter: Sophie X. Deng, MD, PhD, ABO
This content is only available for ASCRS Members

This content from the 2021 ASCRS Annual Meeting is only available to ASCRS members. To log in, click the teal "Login" button in the upper right-hand corner of this page.

Filed Under
Cornea stem cell deficiency limbal stem cell limbal stem cell deficiency ocular surface ocular surface reconstruction
View More Presentations from SYM-19

This presentation is from the session "SYM-19 Challenges and Controversies in the Management of Anterior Segment Diseases" from the 2021 ASCRS Annual Meeting held on July 23-27, 2021 in Las Vegas, Nevada.

View More From This Session
Browse All 2021 ASCRS On Demand Sessions

Related Content

Presentation
Case 1 – Unilateral Non-Inflammatory Limbal Stem Cell Deficiency Case
Melissa Deluvoy, MD 07:13 minutes
April 2022
Presentation
Treatment Approach to Severe Ocular Surface Disease
Edward J. Holland, MD 08:20 minutes
April 2022
Presentation
Case 4 – Diffuse Lscd (non-inflamed) – Primary PKP or Ocular Surface Reconstruction First
Albert Y. Cheung, MD, ABO 07:25 minutes
April 2022
Presentation
Corneal Complications of Glaucoma Treatments
Lisa M. Nijm, MD, JD, ABO 07:01 minutes
July 2021
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2024 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.